Methylation of CpG Sites as Biomarkers Predictive of Drug-Specific Patient Survival in Cancer

BACKGROUND: Though the development of targeted cancer drugs continues to accelerate, doctors still lack reliable methods for predicting patient response to standard-of-care therapies for most cancers. DNA methylation has been implicated in tumor drug response and is a promising source of predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Neary, Bridget, Lin, Shuting, Qiu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634212/
https://www.ncbi.nlm.nih.gov/pubmed/36340286
http://dx.doi.org/10.1177/11769351221131124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634212/
https://www.ncbi.nlm.nih.gov/pubmed/36340286
http://dx.doi.org/10.1177/11769351221131124

Ejemplares similares